Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pneumococcal Vaccine Market 2018, Forecast to 2023

Publisher Name :
Date: 09-Jun-2018
No. of pages: 133

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Scope of the Report:

This report focuses on the Pneumococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.

The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

The worldwide market for Pneumococcal Vaccine is expected to grow at a CAGR of roughly 1.0% over the next five years, will reach 7580 million US$ in 2023, from 7140 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- - Pfizer

- - GSK

- - MSD

- - Sanofipasteur

- - CDIBP

Market Segment by Regions, regional analysis covers

- - North America (United States, Canada and Mexico)

- - Europe (Germany, France, UK, Russia and Italy)

- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- - South America (Brazil, Argentina, Colombia etc.)

- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- - PPSV 23

- - PCV 7/13

- - PCV 10

Market Segment by Applications, can be divided into

- - Child

- - Adult

There are 15 Chapters to deeply display the global Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumococcal Vaccine, with sales, revenue, and price of Pneumococcal Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pneumococcal Vaccine Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 PPSV 23
1.2.2 PCV 7/13
1.2.3 PCV 10
1.3 Market Analysis by Applications
1.3.1 Child
1.3.2 Adult
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Pneumococcal Vaccine Product Introduction
2.1.2.1 Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Pneumococcal Vaccine Product Information
2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Pneumococcal Vaccine Market Share in 2017
2.2 GSK
2.2.1 Business Overview
2.2.1.1 GSK Description
2.2.1.2 GSK Headquarter, Main Business and Finance Overview
2.2.2 GSK Pneumococcal Vaccine Product Introduction
2.2.2.1 Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Pneumococcal Vaccine Product Information
2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GSK Pneumococcal Vaccine Market Share in 2017
2.3 MSD
2.3.1 Business Overview
2.3.1.1 MSD Description
2.3.1.2 MSD Headquarter, Main Business and Finance Overview
2.3.2 MSD Pneumococcal Vaccine Product Introduction
2.3.2.1 Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Pneumococcal Vaccine Product Information
2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global MSD Pneumococcal Vaccine Market Share in 2017
2.4 Sanofipasteur
2.4.1 Business Overview
2.4.1.1 Sanofipasteur Description
2.4.1.2 Sanofipasteur Headquarter, Main Business and Finance Overview
2.4.2 Sanofipasteur Pneumococcal Vaccine Product Introduction
2.4.2.1 Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Pneumococcal Vaccine Product Information
2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sanofipasteur Pneumococcal Vaccine Market Share in 2017
2.5 CDIBP
2.5.1 Business Overview
2.5.1.1 CDIBP Description
2.5.1.2 CDIBP Headquarter, Main Business and Finance Overview
2.5.2 CDIBP Pneumococcal Vaccine Product Introduction
2.5.2.1 Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Pneumococcal Vaccine Product Information
2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global CDIBP Pneumococcal Vaccine Market Share in 2017
3 Global Pneumococcal Vaccine Market Competition, by Manufacturer
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Pneumococcal Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Pneumococcal Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Pneumococcal Vaccine Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales by Regions (2013-2018)
4.1.2 Global Pneumococcal Vaccine Revenue by Regions (2013-2018)
4.2 North America Pneumococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Pneumococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Pneumococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 North America Pneumococcal Vaccine by Countries, Type, Application and Manufacturers
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Pneumococcal Vaccine Sales by Countries (2013-2018)
5.1.2 North America Pneumococcal Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Pneumococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Pneumococcal Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Pneumococcal Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Pneumococcal Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Pneumococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Pneumococcal Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Pneumococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
6 Europe Pneumococcal Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Pneumococcal Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Pneumococcal Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Pneumococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Pneumococcal Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Pneumococcal Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Pneumococcal Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Pneumococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Pneumococcal Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Pneumococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Pneumococcal Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue by Countries (2013-2018)
7.1.3 China Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Pneumococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Pneumococcal Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Pneumococcal Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Pneumococcal Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Pneumococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Pneumococcal Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Pneumococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
8 South America Pneumococcal Vaccine by Countries, Type, Application and Manufacturers
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Pneumococcal Vaccine Sales by Countries (2013-2018)
8.1.2 South America Pneumococcal Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Pneumococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Pneumococcal Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Pneumococcal Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Pneumococcal Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Pneumococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Pneumococcal Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Pneumococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Pneumococcal Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Pneumococcal Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Pneumococcal Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Pneumococcal Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Pneumococcal Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Pneumococcal Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Pneumococcal Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Pneumococcal Vaccine Revenue and Revenue Share by Application (2013-2018)
10 Global Pneumococcal Vaccine Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2013-2018)
10.2 PPSV 23 Sales Growth and Price
10.2.1 Global PPSV 23 Sales Growth (2013-2018)
10.2.2 Global PPSV 23 Price (2013-2018)
10.3 PCV 7/13 Sales Growth and Price
10.3.1 Global PCV 7/13 Sales Growth (2013-2018)
10.3.2 Global PCV 7/13 Price (2013-2018)
10.4 PCV 10 Sales Growth and Price
10.4.1 Global PCV 10 Sales Growth (2013-2018)
10.4.2 Global PCV 10 Price (2013-2018)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2013-2018)
11.2 Child Sales Growth (2013-2018)
11.3 Adult Sales Growth (2013-2018)
12 Pneumococcal Vaccine Market Forecast (2018-2023)
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2018-2023)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2018-2023)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pneumococcal Vaccine Market Forecast (2018-2023)
12.3 Pneumococcal Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2018-2023)
12.4 Pneumococcal Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Pneumococcal Vaccine Picture
Table Product Specifications of Pneumococcal Vaccine
Figure Global Pneumococcal Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Pneumococcal Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Pneumococcal Vaccine by Types in 2017
Figure PPSV 23 Picture
Table Major Manufacturers of PPSV 23
Figure PCV 7/13 Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Picture
Table Major Manufacturers of PCV 10
Figure Pneumococcal Vaccine Sales Market Share by Applications in 2017
Figure Child Picture
Figure Adult Picture
Figure United States Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pneumococcal Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Pfizer Pneumococcal Vaccine Product
Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Pneumococcal Vaccine Sales Market Share in 2017
Figure Global Pfizer Pneumococcal Vaccine Revenue Market Share in 2017
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Pneumococcal Vaccine Product
Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Pneumococcal Vaccine Sales Market Share in 2017
Figure Global GSK Pneumococcal Vaccine Revenue Market Share in 2017
Table MSD Headquarter, Established, Main Business and Finance Overview (2017)
Table MSD Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table MSD Pneumococcal Vaccine Product
Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global MSD Pneumococcal Vaccine Sales Market Share in 2017
Figure Global MSD Pneumococcal Vaccine Revenue Market Share in 2017
Table Sanofipasteur Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofipasteur Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table Sanofipasteur Pneumococcal Vaccine Product
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofipasteur Pneumococcal Vaccine Sales Market Share in 2017
Figure Global Sanofipasteur Pneumococcal Vaccine Revenue Market Share in 2017
Table CDIBP Headquarter, Established, Main Business and Finance Overview (2017)
Table CDIBP Pneumococcal Vaccine Production Bases, Sales Regions and Major Competitors
Table CDIBP Pneumococcal Vaccine Product
Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CDIBP Pneumococcal Vaccine Sales Market Share in 2017
Figure Global CDIBP Pneumococcal Vaccine Revenue Market Share in 2017
Table Global Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Global Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Pneumococcal Vaccine Price by Manufacturer (2016-2017)
Figure Top 3 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Global Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Global Pneumococcal Vaccine Sales by Regions (2013-2018)
Table Global Pneumococcal Vaccine Sales Market Share by Regions (2013-2018)
Table Global Pneumococcal Vaccine Revenue by Regions (2013-2018)
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions in 2013
Figure Global Pneumococcal Vaccine Revenue Market Share by Regions in 2017
Figure North America Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure North America Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Europe Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure South America Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Figure North America Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table North America Pneumococcal Vaccine Sales by Countries (2013-2018)
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2013
Figure North America Pneumococcal Vaccine Sales Market Share by Countries in 2017
Table North America Pneumococcal Vaccine Revenue by Countries (2013-2018)
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2013
Figure North America Pneumococcal Vaccine Revenue Market Share by Countries in 2017
Figure United States Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Table North America Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure North America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table North America Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Pneumococcal Vaccine Sales by Type (2013-2018)
Table North America Pneumococcal Vaccine Sales Share by Type (2013-2018)
Table North America Pneumococcal Vaccine Revenue by Type (2013-2018)
Table North America Pneumococcal Vaccine Revenue Share by Type (2013-2018)
Table North America Pneumococcal Vaccine Sales by Application (2013-2018)
Table North America Pneumococcal Vaccine Sales Share by Application (2013-2018)
Table North America Pneumococcal Vaccine Revenue by Application (2013-2018)
Table North America Pneumococcal Vaccine Revenue Share by Application (2013-2018)
Figure Europe Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Pneumococcal Vaccine Sales by Countries (2013-2018)
Table Europe Pneumococcal Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Pneumococcal Vaccine Revenue by Countries (2013-2018)
Figure Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2016
Figure Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2017
Figure Germany Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure UK Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure France Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Table Europe Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Pneumococcal Vaccine Sales by Type (2013-2018)
Table Europe Pneumococcal Vaccine Sales Share by Type (2013-2018)
Table Europe Pneumococcal Vaccine Revenue by Type (2013-2018)
Table Europe Pneumococcal Vaccine Revenue Share by Type (2013-2018)
Table Europe Pneumococcal Vaccine Sales by Application (2013-2018)
Table Europe Pneumococcal Vaccine Sales Share by Application (2013-2018)
Table Europe Pneumococcal Vaccine Revenue by Application (2013-2018)
Table Europe Pneumococcal Vaccine Revenue Share by Application (2013-2018)
Figure Asia-Pacific Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Pneumococcal Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Countries 2017
Figure China Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure India Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Pneumococcal Vaccine Sales by Type (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales Share by Type (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Revenue by Type (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Revenue Share by Type (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales by Application (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Sales Share by Application (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Revenue by Application (2013-2018)
Table Asia-Pacific Pneumococcal Vaccine Revenue Share by Application (2013-2018)
Figure South America Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table South America Pneumococcal Vaccine Sales by Countries (2013-2018)
Table South America Pneumococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Pneumococcal Vaccine Sales Market Share by Countries in 2017
Table South America Pneumococcal Vaccine Revenue by Countries (2013-2018)
Table South America Pneumococcal Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Pneumococcal Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Table South America Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure South America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure South America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table South America Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure South America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure South America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table South America Pneumococcal Vaccine Sales by Type (2013-2018)
Table South America Pneumococcal Vaccine Sales Share by Type (2013-2018)
Table South America Pneumococcal Vaccine Revenue by Type (2013-2018)
Table South America Pneumococcal Vaccine Revenue Share by Type (2013-2018)
Table South America Pneumococcal Vaccine Sales by Application (2013-2018)
Table South America Pneumococcal Vaccine Sales Share by Application (2013-2018)
Table South America Pneumococcal Vaccine Revenue by Application (2013-2018)
Table South America Pneumococcal Vaccine Revenue Share by Application (2013-2018)
Figure Middle East and Africa Pneumococcal Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Pneumococcal Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Pneumococcal Vaccine Sales and Growth Rate (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Pneumococcal Vaccine Sales by Type (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Sales Share by Type (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Revenue by Type (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Revenue Share by Type (2013-2018)
Table Middle East and Africa Pneumococcal Vaccine Sales by Applicatio
  • 2018-2023 Global Rabies Vaccine Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Rabies Vaccine market for 2018-2023. Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementa......
  • Global and India Legal Marijuana Market Research by Company, Type & Application 2013-2025
    Published: 19-Aug-2018        Price: US 2000 Onwards        Pages: 91
    Summary Marijuana is one of the most abused drugs in the world. And this report studies the Legal Marijuana. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time ......
  • Global and India Fosfomycin Trometamol Market Research by Company, Type & Application 2013-2025
    Published: 18-Aug-2018        Price: US 2000 Onwards        Pages: 98
    Summary Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform. Mainly for the treatment of urinary tract infections such as cystitis, urethritis. Market Segment as follows: By Type - Fosfomycin Tromethamine Granules - Fosfomycin Tromethamine Powder By Application - Common Urinary Tract......
  • Global and India Flu Vaccine Market Research by Company, Type & Application 2013-2025
    Published: 18-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. Market Segment ......
  • Global and India Metabolism Drugs Market Research by Company, Type & Application 2013-2025
    Published: 18-Aug-2018        Price: US 2000 Onwards        Pages: 93
    Summary Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Segment as follows: By Type - Glycogen Metabolism Disease Drug - Lipid Metabolism Disease Drug - Amino Acid Metabolism Drug - Others By Application - Hospital - Retail Pharmacy......
  • Global and India Epinephrine Market Research by Company, Type & Application 2013-2025
    Published: 17-Aug-2018        Price: US 2000 Onwards        Pages: 103
    Summary Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated e......
  • Global Inosine Pranobex Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 135
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Inosine Pranobex Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 133
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • Global and India Codeine Phosphate Market Research by Company, Type & Application 2013-2025
    Published: 17-Aug-2018        Price: US 2000 Onwards        Pages: 98
    Summary Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions. Market Segment as follows: By Type - Extracted from Opium - Synthesized by Morphine By Application - Narcotic Analgesic - Antitussive - Others By Company - Macfarian Smith - Francopia - Noramco - Weifa - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs